Giselle Alexandra Suero Abreu, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma, Endometrial Stromal | 1 | 2020 | 87 | 0.780 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2019 | 109 | 0.690 |
Why?
|
Pneumothorax | 1 | 2020 | 392 | 0.630 |
Why?
|
Heart Neoplasms | 1 | 2020 | 385 | 0.620 |
Why?
|
Manganese | 3 | 2015 | 400 | 0.590 |
Why?
|
Manganese Compounds | 1 | 2014 | 37 | 0.550 |
Why?
|
Vasodilator Agents | 1 | 2019 | 1010 | 0.530 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2019 | 578 | 0.500 |
Why?
|
Contrast Media | 4 | 2017 | 5267 | 0.500 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 560 | 0.490 |
Why?
|
Chlorides | 1 | 2014 | 710 | 0.440 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 516 | 0.430 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 571 | 0.430 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1333 | 0.420 |
Why?
|
Heparin | 1 | 2017 | 1625 | 0.380 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 601 | 0.380 |
Why?
|
Molecular Imaging | 1 | 2017 | 853 | 0.370 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 2910 | 0.360 |
Why?
|
Medulloblastoma | 1 | 2014 | 715 | 0.360 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 3970 | 0.320 |
Why?
|
Quality Improvement | 2 | 2022 | 3733 | 0.310 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2371 | 0.300 |
Why?
|
Anticoagulants | 2 | 2020 | 4293 | 0.290 |
Why?
|
Image Enhancement | 1 | 2015 | 2975 | 0.250 |
Why?
|
Neoplasms | 2 | 2022 | 20172 | 0.240 |
Why?
|
Anthracyclines | 2 | 2022 | 254 | 0.230 |
Why?
|
Heart Failure | 3 | 2022 | 10040 | 0.230 |
Why?
|
Melanoma | 1 | 2020 | 5194 | 0.230 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5266 | 0.220 |
Why?
|
Internship and Residency | 1 | 2021 | 5556 | 0.210 |
Why?
|
Esophagitis, Peptic | 1 | 2021 | 65 | 0.210 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 34151 | 0.200 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2021 | 137 | 0.200 |
Why?
|
Symporters | 1 | 2022 | 366 | 0.180 |
Why?
|
Stroke | 2 | 2021 | 9256 | 0.180 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18375 | 0.180 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 179 | 0.180 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2021 | 465 | 0.170 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2020 | 290 | 0.160 |
Why?
|
Biotinylation | 1 | 2017 | 186 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2020 | 12183 | 0.150 |
Why?
|
Receptor, TIE-2 | 1 | 2017 | 188 | 0.150 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 679 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11253 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 895 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2020 | 1114 | 0.130 |
Why?
|
Atlases as Topic | 1 | 2015 | 236 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2020 | 1505 | 0.130 |
Why?
|
Subcellular Fractions | 1 | 2014 | 576 | 0.130 |
Why?
|
Pneumonectomy | 1 | 2020 | 1066 | 0.120 |
Why?
|
Transgenes | 1 | 2017 | 1026 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2017 | 1887 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 3984 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2014 | 1611 | 0.100 |
Why?
|
Medical Oncology | 1 | 2022 | 2098 | 0.100 |
Why?
|
Cation Transport Proteins | 1 | 2012 | 330 | 0.100 |
Why?
|
Animals, Newborn | 1 | 2015 | 2877 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2176 | 0.090 |
Why?
|
Disease Progression | 2 | 2017 | 13298 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1338 | 0.090 |
Why?
|
Pyrimidines | 1 | 2021 | 2950 | 0.090 |
Why?
|
Kinetics | 1 | 2017 | 6796 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1537 | 0.090 |
Why?
|
Brain | 1 | 2015 | 24969 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3097 | 0.080 |
Why?
|
Humans | 14 | 2022 | 708843 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 14075 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2022 | 3228 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 5112 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2913 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5405 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9927 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2017 | 3417 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5918 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 4454 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 8014 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2014 | 3075 | 0.060 |
Why?
|
Animals | 5 | 2017 | 170486 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22989 | 0.050 |
Why?
|
Mice | 4 | 2015 | 80876 | 0.050 |
Why?
|
Middle Aged | 6 | 2021 | 213752 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10803 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2014 | 3995 | 0.050 |
Why?
|
Prescriptions | 1 | 2022 | 335 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2014 | 15274 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 10857 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13714 | 0.040 |
Why?
|
Orbit | 1 | 2021 | 430 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 61932 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1637 | 0.040 |
Why?
|
Female | 5 | 2021 | 375205 | 0.030 |
Why?
|
Molecular Probe Techniques | 1 | 2014 | 117 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2866 | 0.030 |
Why?
|
Molecular Probes | 1 | 2014 | 326 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 41038 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3944 | 0.030 |
Why?
|
Protein Engineering | 1 | 2014 | 551 | 0.030 |
Why?
|
Recovery of Function | 1 | 2021 | 2950 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4261 | 0.020 |
Why?
|
Adult | 2 | 2021 | 211041 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2012 | 1019 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5139 | 0.020 |
Why?
|
Male | 3 | 2021 | 349524 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6257 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5095 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10339 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7763 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13274 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4310 | 0.020 |
Why?
|
Risk Factors | 2 | 2021 | 69553 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2022 | 71483 | 0.020 |
Why?
|
Incidence | 1 | 2021 | 20320 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9639 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23284 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16959 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58184 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 55940 | 0.010 |
Why?
|
United States | 1 | 2021 | 67165 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 84718 | 0.010 |
Why?
|
Aged | 1 | 2021 | 161488 | 0.010 |
Why?
|